2025 Onco MKT internship

Amissville, Virginia, United States

Auto‑apply with AI Apply

Not SpecifiedCompensation

InternshipExperience Level

Full TimeJob Type

UnknownVisa

PharmaceuticalsIndustries

Requirements

Candidates should possess a Bachelor's degree in Marketing, Business Administration, or a related field, and ideally some prior internship experience. Strong communication and interpersonal skills are essential, along with the ability to quickly learn and apply new information.

Responsibilities

The 2025 Onco MKT Intern will support the Oncology Marketing team by assisting with the development and execution of marketing strategies for the BC portfolio. This includes creating patient case books, organizing and visualizing data for the data library, and contributing to the planning and production of promotional materials for sales detailers, ultimately aiming to improve patient outcomes and align with the broader EBC strategy.

Skills

Data visualization

Graph analysis

Promotion material planning

Healthcare marketing

Pharmaceutical industry knowledge

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free